Assignee
AERPIO PHARMACEUTICALS INC
US·5 granted patents·12 pending applications·23 citations·filing 2016–2021
Top patents by PatentIndex Score
17 records- 0195US11136389B2Humanized monoclonal antibodies that target VE-PTP (HPTP-β)AERPIO PHARMACEUTICALS INC·Filed 2020·Granted Oct 5, 2021·5 cites·33 claims
- 0292US10894824B2Multispecific antibodies that target HPTP-β (VE-PTP) and VEGFAERPIO PHARMACEUTICALS INC·Filed 2019·Granted Jan 19, 2021·6 cites·32 claims
- 0388US10815300B2Methods for treating vascular leak syndrome and cancerAERPIO PHARMACEUTICALS INC·Filed 2018·Granted Oct 27, 2020·5 cites·11 claims
- 0486US10952992B2Methods of treating intraocular pressure with activators of Tie-2AERPIO PHARMACEUTICALS INC·Filed 2016·Granted Mar 23, 2021·4 cites·32 claims
- 0581US10858354B2HPTP-Beta inhibitorsAERPIO PHARMACEUTICALS INC·Filed 2018·Granted Dec 8, 2020·3 cites·3 claims
- 0678US2020207730A1Methods for treating vascular leak syndromeAERPIO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0776US2022117946A1Human protein tyrosine phosphatase inhibitors and methods of useAERPIO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0875US2020253936A1Human protein tyrosine phosphatase inhibitors and methods of useAERPIO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0973US2020361926A1Compositions, formulations and methods for treating ocular diseasesAERPIO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1071US2020277267A1Methods for treating vascular leak syndromeAERPIO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1169US2020108080A1Compositions and methods for treating ocular diseasesAERPIO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1269US2020009115A1Compositions and methods for treating ocular edema, neovascularization and related diseasesAERPIO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1369US2022016086A1Compositions and methods for treating ocular edema, neovascularization and related diseasesAERPIO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1468US2020231703A1Treatment of ocular diseaseAERPIO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1563US2021130341A1Hptp-beta inhibitorsAERPIO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1653US2021212998A1Combinations of Tie-2 Activators and Prostaglandins and Uses ThereofAERPIO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1748US2020352914A1Methods of treating hypertension with activators of tie-2AERPIO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →